-
Information on medical device licensing in each province (as of August 31, 2022)
Time of Update: 2022-10-03
In order to further meet the needs of enterprises and the public to inquire about medical device regulatory information and strengthen social supervision and social co-governance, the State Food and
-
The research progress of BCMA CAR-T product CT053 North America Phase 2 of Keji Pharmaceutical was presented at the 7th CAR-TCR Annual Summit
Time of Update: 2022-10-02
HK), an innovative CAR-T cell therapy company focused primarily on the treatment of hematologic malignancies and solid tumors, announced that at the 7th annual CAR-TCR Summit in Boston, Massachusetts, the company orally presented Zevor-cel (product number: CT053) (an autologous CAR-T candidate for BCMA) North America2 Phase clinical trials.
-
Chengqi Biologics' gene sequencing analysis cloud platform based on the FANSe algorithm was successfully run on AWS
Time of Update: 2022-10-02
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Kexing Pharmaceutical Changlekang was awarded the "2021~2022 Chinese Family Shelf Medicine Listed Brand"
Time of Update: 2022-10-02
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Merck invested €29 million to open a biosafety testing laboratory in Shanghai
Time of Update: 2022-10-02
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
WuXi Biologics' two stock solutions plants and one preparation plant have obtained GMP certification for multiple products of the US FDA and the EU EMA
Time of Update: 2022-10-02
WuXi Biologics Plant 4 (MFG4), Liquid 5 (MFG5) and Preparation Unit 2 successfully passed the EMA's online pre-market approval inspection (PAI) for two products produced by the company for two global customers, and obtained GMP certification.
-
Rheumatoid arthritis drugs are effective for muscle weakness
Time of Update: 2022-10-02
That's based on a randomized clinical study led by researchers at the Karolinska Institute in Sweden, published in the journal JAMA Neurology"Patients with new-onset myasthenia who received Merohua as a supplement to standard of care showed greater improvement compared to patients taking a placebo," said Fredrik Piehl, a professor in the Department of Clinical Neuroscience at Karolinska Medical College and principal investigator of the study.
-
BeiGene Baiyueze? (Zebutinib) has received positive advice from the European Medicines Agency's Committee on Pharmaceuticals for Human Use in support of its use in the treatment of adult patients with lymphoma in the marginal region
Time of Update: 2022-10-02
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Two-sided needle company for ten consecutive years to the "ASEAN Treaty"
Time of Update: 2022-10-02
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Notice on the time adjustment of the "2022 19th China (Nanjing) International Scientific Instruments and Laboratory Equipment Exhibition"
Time of Update: 2022-10-02
Dear exhibitors, visitors, partners and other colleagues from all walks of life:Thank you for your active participation, full attention and strong support for the 19th China (Nanjing) International Sc
-
Long awaited! MERFISH super-resolution spatial transcriptomics technology service is finally here!
Time of Update: 2022-10-02
Realize the true sense of in situ single-cell spatial genome analysis, visualize the expression and localization of genes, and promote the research of genomics into the next generation!Advantages of MERFISH spatial transcriptome technology1.
-
Thermo Scientific announces investment in Guangzhou to build a Guangdong-Hong Kong-Macao Greater Bay Area base
Time of Update: 2022-10-02
After the completion of the Guangdong-Hong Kong-Macao Greater Bay Area Base, it will make full use of Thermo Fisher's cutting-edge technology advantages in the field of scientific services to produce high-value-added products including high-end laboratory equipment, analytical instruments and laboratory consumables.
-
In August, the United States, the United States and Europe approved the inventory of new drugs on the market
Time of Update: 2022-10-01
The drug was approved based on the results of its phase III clinical trial: the efficacy of repatumab-CHOP and rituximab-CHOP in the treatment of patients with initially treated diffuse large B-cell lymphoma was comparable.
-
Shanghai Hehuang Pharmaceutical, as the only pharmaceutical company in Shanghai, was awarded the "National Harmonious Labor Relations Demonstration and Creation Enterprise"
Time of Update: 2022-10-01
62em; font-family:"Arial"; color:black; margin:0in; } Shanghai, September 22, 2022 /PRNewswire/ -- Recently, the Ministry of Human Resources and Social Security, the All-China Federation of Trade Unions, the China Enterprise Confederation/China Entrepreneurs Association, and the All-China Federation of Industry and Commerce jointly released the "List of Demonstration Enterprises for the Creation of Harmonious Labor Relations in China", and Shanghai Hehuang Pharmaceutical was awarded the title of "National Demonstration and Creation Enterprise of Harmonious Labor Relations".
-
【Jingderui Live】Frequently Asked Questions and Answers of Pharmaceutical Water System
Time of Update: 2022-09-30
Guide: At 14:00 pm on September 22, Jingderui will bring you the theme of "Pharmaceutical Water System FAQs" live broadcast, share with you some common problems of pharmaceutical water systems, welcome to watch on time!
-
The domestic proton therapy system was approved for use and its performance was comparable to that of imported similar devices
Time of Update: 2022-09-30
The reporter learned on the 27th that the State Drug Administration approved the application for registration of innovative products of "proton therapy system" produced by Shanghai enterprises. In th
-
Fluidized bed granulation has obvious advantages, and pharmaceutical machinery companies are actively integrating more advanced technologies into their products
Time of Update: 2022-09-30
In this context, the traditional granulation process obviously cannot fully meet the conditions of certified enterprises, therefore, fluidized bed granulation is widely recognized and applied by pharmaceutical companies due to its advantages of high production efficiency, short cycle and GMP requirements.
-
Warm congratulations on the successful conclusion of the 21st National Plant Genomics Conference! 【GeneSpeed centrifuge winning the lottery announced】
Time of Update: 2022-09-25
The conference was hosted by the Plant and Genome Professional Committee of the Chinese Genetic Society, and hosted by Guangxi University and the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences.
-
Tiosbio's two CRISPR dual-target nucleic acid detection test strips are shocking
Time of Update: 2022-09-21
At present, the widely commercialized CRISPR nucleic acid detection test strips on the market can only display the cutting products of a single reporter molecule, so although a large number of heavy-level research results have been formed in the field of scientific research, it is still difficult to meet the IVD industry's demand for double-target positive detection of the same sample, so it has not been widely used.
-
China Center for Disease Control and Prevention: Accelerated mutation of the new crown virus The five major branches are generally not much different
Time of Update: 2022-09-21
On the other hand, the use of vaccines on a global scale and the formation of an immune barrier in a large number of naturally infected people in a short period of time will also accelerate the mutation of the new crown virus.
